CS
MRTX
Candriam SCA’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-893,763
| Closed | -$38.9M | – | 731 |
|
|
2023
Q3 | $38.9M | Buy |
893,763
+20,000
| +2% | +$871K | 0.28% | 76 |
|
|
2023
Q2 | $31.6M | Buy |
873,763
+109,498
| +14% | +$3.96M | 0.23% | 113 |
|
|
2023
Q1 | $26.2M | Sell |
764,265
-3,331
| -0.4% | -$114K | 0.18% | 134 |
|
|
2022
Q4 | $34.8M | Buy |
767,596
+105,095
| +16% | +$4.76M | 0.23% | 101 |
|
|
2022
Q3 | $46.3M | Buy |
662,501
+68,217
| +11% | +$4.76M | 0.33% | 72 |
|
|
2022
Q2 | $39.9M | Buy |
594,284
+87,511
| +17% | +$5.87M | 0.33% | 75 |
|
|
2022
Q1 | $41.7M | Buy |
506,773
+14,290
| +3% | +$1.17M | 0.28% | 84 |
|
|
2021
Q4 | $72.2M | Buy |
492,483
+109,264
| +29% | +$16M | 0.46% | 51 |
|
|
2021
Q3 | $67.8M | Buy |
383,219
+37,623
| +11% | +$6.66M | 0.46% | 50 |
|
|
2021
Q2 | $55.8M | Buy |
345,596
+156,496
| +83% | +$25.3M | 0.38% | 57 |
|
|
2021
Q1 | $39.9M | Buy |
189,100
+2
| +0% | +$422 | 0.33% | 72 |
|
|
2020
Q4 | $41.5M | Buy |
189,098
+55,961
| +42% | +$12.3M | 0.33% | 72 |
|
|
2020
Q3 | $22.1M | Buy |
133,137
+23,076
| +21% | +$3.83M | 0.21% | 124 |
|
|
2020
Q2 | $12.6M | Buy |
110,061
+10,733
| +11% | +$1.23M | 0.13% | 180 |
|
|
2020
Q1 | $12.5M | Buy |
99,328
+5
| +0% | +$630 | 0.14% | 170 |
|
|
2019
Q4 | $12.8M | Sell |
99,323
-22,977
| -19% | -$2.96M | 0.14% | 171 |
|
|
2019
Q3 | $9.53M | Sell |
122,300
-34,700
| -22% | -$2.7M | 0.13% | 193 |
|
|
2019
Q2 | $16.1M | Buy |
157,000
+44,000
| +39% | +$4.51M | 0.2% | 115 |
|
|
2019
Q1 | $8.28M | Sell |
113,000
-98,000
| -46% | -$7.18M | 0.11% | 226 |
|
|
2018
Q4 | $8.95M | Buy |
211,000
+19,000
| +10% | +$806K | 0.14% | 176 |
|
|
2018
Q3 | $9.04M | Buy |
192,000
+99,300
| +107% | +$4.68M | 0.12% | 204 |
|
|
2018
Q2 | $4.57M | Buy |
+92,700
| New | +$4.57M | 0.07% | 311 |
|
|
2016
Q3 | – | Sell |
-70,000
| Closed | -$382K | – | 682 |
|
|
2016
Q2 | $382K | Sell |
70,000
-34,000
| -33% | -$186K | 0.01% | 600 |
|
|
2016
Q1 | $2.21M | Sell |
104,000
-11,000
| -10% | -$234K | 0.06% | 306 |
|
|
2015
Q4 | $3.63M | Buy |
115,000
+8,000
| +7% | +$253K | 0.1% | 222 |
|
|
2015
Q3 | $3.68M | Sell |
107,000
-3,000
| -3% | -$103K | 0.09% | 246 |
|
|
2015
Q2 | $3.46M | Sell |
110,000
-4,000
| -4% | -$126K | 0.07% | 289 |
|
|
2015
Q1 | $3.34M | Buy |
114,000
+44,000
| +63% | +$1.29M | 0.07% | 318 |
|
|
2014
Q4 | $1.3M | Buy |
+70,000
| New | +$1.3M | 0.03% | 414 |
|